Insulet (PODD) Competitors

Insulet (NASDAQ:PODD) and Teleflex (NYSE:TFX) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, community ranking, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Does the media refer more to PODD or TFX?

In the previous week, Insulet had 5 more articles in the media than Teleflex. MarketBeat recorded 10 mentions for Insulet and 5 mentions for Teleflex. Insulet's average media sentiment score of 1.25 beat Teleflex's score of 1.11 indicating that Insulet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	7 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings and valuation, PODD or TFX?

Teleflex has higher revenue and earnings than Insulet. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$1.70B	7.18	$206.30M	$2.91	59.77
Teleflex	$2.97B	3.34	$356.33M	$7.53	27.98

Is PODD or TFX more profitable?

Insulet has a net margin of 12.16% compared to Teleflex's net margin of 11.98%. Insulet's return on equity of 32.19% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	12.16%	32.19%	7.93%
Teleflex	11.98%	14.98%	8.87%

Do insiders and institutionals hold more shares of PODD or TFX?

95.6% of Teleflex shares are owned by institutional investors. 0.8% of Insulet shares are owned by company insiders. Comparatively, 1.4% of Teleflex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Which has more volatility and risk, PODD or TFX?

Insulet has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500.

Do analysts rate PODD or TFX?

Insulet presently has a consensus price target of $250.33, suggesting a potential upside of 43.92%. Teleflex has a consensus price target of $265.56, suggesting a potential upside of 26.06%. Given Insulet's stronger consensus rating and higher possible upside, research analysts clearly believe Insulet is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Teleflex	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

Does the MarketBeat Community prefer PODD or TFX?

Insulet received 190 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 65.98% of users gave Insulet an outperform vote while only 59.68% of users gave Teleflex an outperform vote.

Company	Underperform	Outperform
Insulet	Outperform Votes 708 65.98%	Underperform Votes 365 34.02%
Teleflex	Outperform Votes 518 59.68%	Underperform Votes 350 40.32%

Summary

Insulet beats Teleflex on 11 of the 18 factors compared between the two stocks.